CpG island methylation patterns in chronic lymphocytic leukemia

References

• Chiorazzi N, Rai K R, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804–815
   PubMed Web of Science ®Google Scholar
• Dores G M, Anderson W F, Curtis R E, Landgren O, Ostroumova E, Bluhm E C, et al. Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology. Br J Haematol 2007; 139: 809–819
   PubMed Web of Science ®Google Scholar
• Rai K R, Sawitsky A, Cronkite E P, Chanana A D, Levy R N, Pasternack B S. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234
   PubMed Web of Science ®Google Scholar
• Binet J L, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48: 198–206
   PubMed Web of Science ®Google Scholar
• Caporaso N, Goldin L, Plass C, Calin G, Marti G, Bauer S, et al. Chronic lymphocytic leukaemia genetics overview. Br J Haematol 2007; 139: 630–634
   PubMed Web of Science ®Google Scholar
• Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910–1916
   PubMed Web of Science ®Google Scholar
• Oscier D G, Gardiner A C, Mould S J, Glide S, Davis Z A, Ibbotson R E, et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002; 100: 1177–1184
   PubMed Web of Science ®Google Scholar
• Zenz T, Krober A, Scherer K, Habe S, Buhler A, Benner A, et al. Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up. Blood 2008; 112: 3322–3329
   PubMed Web of Science ®Google Scholar
• Hamblin T J, Davis Z, Gardiner A, Oscier D G, Stevenson F K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848–1854
   PubMed Web of Science ®Google Scholar
• Damle R N, Wasil T, Fais F, Ghiotto F, Valetto A, Allen S L, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–1847
   PubMed Web of Science ®Google Scholar
• Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003; 348: 1764–1775
   PubMed Web of Science ®Google Scholar
• Faderl S J, Keating M J. Treatment of chronic lymphocytic leukemia. Curr Hematol Rep 2005; 4: 31–38
   PubMedGoogle Scholar
• Carney D A, Wierda W G. Genetics and molecular biology of chronic lymphocytic leukemia. Curr Treat Options Oncol 2005; 6: 215–225
   PubMedGoogle Scholar
• Esteller M. Epigenetics in cancer. N Engl J Med 2008; 358: 1148–1159
   PubMed Web of Science ®Google Scholar
• Jost E, Galm O. EHA scientific workshop report: the role of epigenetics in hematological malignancies. Epigenetics 2007; 2: 71–79
   PubMed Web of Science ®Google Scholar
• Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006; 439: 871–874
   PubMed Web of Science ®Google Scholar
• Volpe T A, Kidner C, Hall I M, Teng G, Grewal S I, Martienssen R A. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 2002; 297: 1833–1837
   PubMed Web of Science ®Google Scholar
• Boultwood J, Wainscoat J S. Gene silencing by DNA methylation in haematological malignancies. Br J Haematol 2007; 138: 3–11
   PubMed Web of Science ®Google Scholar
• Jones P A, Baylin S B. The epigenomics of cancer. Cell 2007; 128: 683–692
   PubMed Web of Science ®Google Scholar
• Raval A, Byrd J C, Plass C. Epigenetics in chronic lymphocytic leukemia. Semin Oncol 2006; 33: 157–166
   PubMed Web of Science ®Google Scholar
• Calin G A, Liu C G, Sevignani C, Ferracin M, Felli N, Dumitru C D, et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 2004; 101: 11755–11760
   PubMed Web of Science ®Google Scholar
• Plass C, Byrd J C, Raval A, Tanner S M, de la Chapelle A. Molecular profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genes. Br J Haematol 2007; 139: 744–752
   PubMed Web of Science ®Google Scholar
• Calin G A, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik S E, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793–1801
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg R A. The hallmarks of cancer. Cell 2000; 100: 57–70
   PubMed Web of Science ®Google Scholar
• Rush L J, Raval A, Funchain P, Johnson A J, Smith L, Lucas D M, et al. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Res 2004; 64: 2424–2433
   PubMed Web of Science ®Google Scholar
• Galm O, Herman J G, Baylin S B. The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev 2006; 20: 1–13
   PubMed Web of Science ®Google Scholar
• Chim C S, Fung T K, Wong K F, Lau J S, Liang R. Frequent DAP kinase but not p14 or Apaf-1 hypermethylation in B-cell chronic lymphocytic leukemia. J Hum Genet 2006; 51: 832–838
   PubMed Web of Science ®Google Scholar
• Chim C S, Pang R, Liang R. Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia. J Clin Pathol 2008; 61: 1214–1219
   PubMed Web of Science ®Google Scholar
• Galm O, Suzuki H, Akiyama Y, Esteller M, Brock M V, Osieka R, et al. Inactivation of the tissue inhibitor of metalloproteinases-2 gene by promoter hypermethylation in lymphoid malignancies. Oncogene 2005; 24: 4799–4805
   PubMed Web of Science ®Google Scholar
• Herman J G, Civin C I, Issa J P, Collector M I, Sharkis S J, Baylin S B. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res 1997; 57: 837–841
   PubMed Web of Science ®Google Scholar
• Katzenellenbogen R A, Baylin S B, Herman J G. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood 1999; 93: 4347–4353
   PubMed Web of Science ®Google Scholar
• Liu T H, Raval A, Chen S S, Matkovic J J, Byrd J C, Plass C. CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia. Cancer Res 2006; 66: 653–658
   PubMed Web of Science ®Google Scholar
• Melki J R, Vincent P C, Brown R D, Clark S J. Hypermethylation of E-cadherin in leukemia. Blood 2000; 95: 3208–3213
   PubMed Web of Science ®Google Scholar
• Rossi D, Capello D, Gloghini A, Franceschetti S, Paulli M, Bhatia K, et al. Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia. Haematologica 2004; 89: 154–164
   PubMed Web of Science ®Google Scholar
• Herman J G, Graff J R, Myohanen S, Nelkin B D, Baylin S B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821–9826
   PubMed Web of Science ®Google Scholar
• Galm O, Wilop S, Luders C, Jost E, Gehbauer G, Herman J G, et al. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia. Ann Hematol 2005; 84(Suppl. 13)39–46
   PubMed Web of Science ®Google Scholar
• Galm O, Wilop S, Reichelt J, Jost E, Gehbauer G, Herman J G, et al. DNA methylation changes in multiple myeloma. Leukemia 2004; 18: 1687–1692
   PubMed Web of Science ®Google Scholar
• Galm O, Yoshikawa H, Esteller M, Osieka R, Herman J G. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood 2003; 101: 2784–2788
   PubMed Web of Science ®Google Scholar
• Suzuki H, Watkins D N, Jair K W, Schuebel K E, Markowitz S D, Chen W D, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004; 36: 417–422
   PubMed Web of Science ®Google Scholar
• Galm O, Herman J G. Methylation-specific polymerase chain reaction. Methods Mol Med 2005; 113: 279–291
   Google Scholar
• Jost E, Schmid J, Wilop S, Schubert C, Suzuki H, Herman J G, et al. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia. Br J Haematol 2008; 142: 745–753
   PubMed Web of Science ®Google Scholar
• Roman-Gomez J, Cordeu L, Agirre X, Jimenez-Velasco A, San Jose-Eneriz E, Garate L, et al. Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. Blood 2007; 109: 3462–3469
   PubMed Web of Science ®Google Scholar
• Raval A, Tanner S M, Byrd J C, Angerman E B, Perko J D, Chen S S, et al. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 2007; 129: 879–890
   PubMed Web of Science ®Google Scholar
• Kuphal F, Behrens J. E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts. Exp Cell Res 2006; 312: 457–467
   PubMed Web of Science ®Google Scholar
• Papageorgiou S G, Lambropoulos S, Pappa V, Economopoulou C, Kontsioti F, Papageorgiou E, et al. Hypermethylation of the p15INK4B gene promoter in B-chronic lymphocytic leukemia. Am J Hematol 2007; 82: 824–825
   PubMed Web of Science ®Google Scholar
• Martel V, Guerci A, Humbert J C, Gregoire M J, Chery M, Lederlin P, et al. De novo methylation of tumour suppressor genes CDKN2A and CDKN2B is a rare finding in B-cell chronic lymphocytic leukaemia. Br J Haematol 1997; 99: 320–324
   PubMed Web of Science ®Google Scholar
• Chim C S, Fung T K, Wong K F, Lau J S, Law M, Liang R. Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients. J Clin Pathol 2006; 59: 921–926
   PubMed Web of Science ®Google Scholar
• Pinyol M, Cobo F, Bea S, Jares P, Nayach I, Fernandez P L, et al. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood 1998; 91: 2977–2984
   PubMed Web of Science ®Google Scholar
• Baur A S, Shaw P, Burri N, Delacretaz F, Bosman F T, Chaubert P. Frequent methylation silencing of p15(INK4b) (MTS2) and p16(INK4a) (MTS1) in B-cell and T-cell lymphomas. Blood 1999; 94: 1773–1781
   PubMed Web of Science ®Google Scholar
• Tsirigotis P, Pappa V, Labropoulos S, Papageorgiou S, Kontsioti F, Dervenoulas J, et al. Mutational and methylation analysis of the cyclin-dependent kinase 4 inhibitor (p16INK4A) gene in chronic lymphocytic leukemia. Eur J Haematol 2006; 76: 230–236
   PubMed Web of Science ®Google Scholar
• Fulop Z, Csernus B, Timar B, Szepesi A, Matolcsy A. Microsatellite instability and hMLH1 promoter hypermethylation in Richter's transformation of chronic lymphocytic leukemia. Leukemia 2003; 17: 411–415
   PubMed Web of Science ®Google Scholar
• Esteller M, Hamilton S R, Burger P C, Baylin S B, Herman J G. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999; 59: 793–797
   PubMed Web of Science ®Google Scholar
• Corn P G, Kuerbitz S J, van Noesel M M, Esteller M, Compitello N, Baylin S B, et al. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation. Cancer Res 1999; 59: 3352–3356
   PubMed Web of Science ®Google Scholar
• Novak U, Grob T J, Baskaynak G, Peters U R, Aebi S, Zwahlen D, et al. Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia. Ann Oncol 2001; 12: 981–986
   PubMed Web of Science ®Google Scholar
• Shanafelt T D, Geyer S M, Kay N E. Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL. Blood 2004; 103: 1202–1210
   PubMed Web of Science ®Google Scholar
• Irizarry R A, Ladd-Acosta C, Carvalho B, Wu H, Brandenburg S A, Jeddeloh J A, et al. Comprehensive high-throughput arrays for relative methylation (CHARM). Genome Res 2008; 18: 780–790
   PubMed Web of Science ®Google Scholar
• Claus R, Almstedt M, Lubbert M. Epigenetic treatment of hematopoietic malignancies: in vivo targets of demethylating agents. Semin Oncol 2005; 32: 511–520
   PubMed Web of Science ®Google Scholar
• Kantarjian H M, O'Brien S, Huang X, Garcia-Manero G, Ravandi F, Cortes J, et al. Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experience. Cancer 2007; 109: 1133–1137
   PubMed Web of Science ®Google Scholar
• Issa J P, Byrd J C. Decitabine in chronic leukemias. Semin Hematol 2005; 42(3 Suppl. 2)S43–S49
   PubMed Web of Science ®Google Scholar
• Opavsky R, Wang S H, Trikha P, Raval A, Huang Y, Wu Y Z, et al. CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells. PLoS Genet 2007; 3: 1757–1769
   PubMed Web of Science ®Google Scholar
• Rawstron A C, Bennett F L, O'Connor S J, Kwok M, Fenton J A, Plummer M, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008; 359: 575–583
   PubMed Web of Science ®Google Scholar
• Corcoran M, Parker A, Orchard J, Davis Z, Wirtz M, Schmitz O J, et al. ZAP-70 methylation status is associated with ZAP-70 expression status in chronic lymphocytic leukemia. Haematologica 2005; 90: 1078–1088
   PubMed Web of Science ®Google Scholar
• Caldwell G M, Jones C, Gensberg K, Jan S, Hardy R G, Byrd P, et al. The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res 2004; 64: 883–888
   PubMed Web of Science ®Google Scholar
• Taylor K H, Kramer R S, Davis J W, Guo J, Duff D J, Xu D, et al. Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res 2007; 67: 8511–8518
   PubMed Web of Science ®Google Scholar